Moderna, Inc. — Director's Dealing 2020

Jul 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-07-27

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-27	Common Stock	M	10000	$20.93	Acquired	10000	Direct
2020-07-27	Common Stock	M	10000	$19.15	Acquired	20000	Direct
2020-07-27	Common Stock	S	2384	$76.79	Disposed	17616	Direct
2020-07-27	Common Stock	S	3940	$77.68	Disposed	13676	Direct
2020-07-27	Common Stock	S	5548	$78.73	Disposed	8128	Direct
2020-07-27	Common Stock	S	7228	$79.72	Disposed	900	Direct
2020-07-27	Common Stock	S	900	$80.43	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-27	Stock Option (Right to Buy)	$20.93	M	10000	Disposed	2029-03-08	Common Stock (10000)	Direct
2020-07-27	Stock Option (Right to Buy)	$19.15	M	10000	Disposed	2026-08-10	Common Stock (10000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.19 to $77.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.20 to $78.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.21 to $79.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.22 to $80.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.27 to $80.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: This option is fully vested and exercisable.

F8: This option is fully vested and exercisable.